Fair Value Of Financial Instruments (Tables)

6 Months Ended

Mar. 31, 2020

Fair Value of Financial Instruments

Summary of assets and liabilities measured and recorded at fair value on Balance Sheet on a recurring basis

The following table presents assets and liabilities measured and recorded at fair value on our Condensed Consolidated Balance Sheets on a recurring basis (in thousands):

	March 31, 2020								September 30, 2019
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets
Current derivative assets	$	—	$	5,540	$	—	$	5,540	$	—	$	2,635	$	—	$	2,635
Noncurrent derivative assets		—		4,061		—		4,061		—		859		—		859
Total assets measured at fair value	$	—	$	9,601	$	—	$	9,601	$	—	$	3,494	$	—	$	3,494
Liabilities
Current derivative liabilities		—		1,657		—		1,657		—		529		—		529
Noncurrent derivative liabilities		—		5,023		—		5,023		—		228		—		228
Contingent consideration to seller of H4 Global		—		—		564		564		—		—		1,073		1,073
Contingent consideration to seller of Deltenna		—		—		2,810		2,810		—		—		1,787		1,787
Contingent consideration to seller of Shield		—		—		3,022		3,022		—		—		3,814		3,814
Contingent consideration to seller of Nuvotronics		—		—		—		—		—		—		4,200		4,200
Contingent consideration to seller of Delerrok		—		—		1,600		1,600		—		—		—		—
Total liabilities measured at fair value	$	—	$	6,680	$	7,996	$	14,676	$	—	$	757	$	10,874	$	11,631

Summary of change in fair value of contingent consideration liability

As of March 31, 2020, the following table summarizes the change in fair value of our Level 3 contingent consideration liabilities (in thousands):

	H4 Global		Deltenna		Shield		Nuvotronics		Delerrok		Total
Balance as of September 30, 2019	$	1,073	$	1,787	$	3,814	$	4,200	$	—	$	10,874
Initial measurement recognized at acquisition		—		—		—		—		1,600		1,600
Total remeasurement (gain) loss recognized in earnings		(509)		1,023		(792)		(4,200)		—		(4,478)
Balance as of March 31, 2020	$	564	$	2,810	$	3,022	$	—	$	1,600	$	7,996